Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-4233
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining ; day:31 ; month:7 ; year:2018 ; pages:1-6
Breast cancer ; (31.7.2018), 1-6
- Urheber
-
Kuroda, Hajime
- Beteiligte Personen und Organisationen
-
Muroi, Nozomi
Hayashi, Mitsuhiro
Harada, Oi
Hoshi, Kazuei
Fukuma, Eisuke
Abe, Akihito
Kubota, Keiichi
Imai, Yasuo
SpringerLink (Online service)
- DOI
-
10.1007/s12282-018-0898-9
- URN
-
urn:nbn:de:101:1-2018100219023329974250
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuroda, Hajime
- Muroi, Nozomi
- Hayashi, Mitsuhiro
- Harada, Oi
- Hoshi, Kazuei
- Fukuma, Eisuke
- Abe, Akihito
- Kubota, Keiichi
- Imai, Yasuo
- SpringerLink (Online service)
Ähnliche Objekte (12)
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers